Meropenem (trihydrate) - CAS# 119478-56-7 Size:Solid 2 mg Formula: C16H17BrClN3O3

Formula: C16H17BrClN3O3

enables oncogenic transformation

12-hexaene hydrochloride

and 30 mg/kg

CID16020046 concentration dependently inhibited lysophosphatidylinositol (LPI)-induced activation of nuclear factor of activated T-cells (NFAT)

Meropenem (trihydrate) - CAS# 119478-56-7 Size:Solid 2 mg Formula: C16H17BrClN3O3Meropenem is an ultra broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. Meropenem was originally developed by Sumitomo Pharmaceuticals. It is marketed outside Japan by AstraZeneca with the brand names Merrem and Meronem. Other brand names include Zwipen (India, Marketed by Nucleus) Mepem